(Adnkronos) - In questo numero:
‘Patto per l’eliminazione dell’epatite C’, insieme società scientifiche. pazienti e istituzioni
Innovative lenti intraoculari Icl valida alternativa a intervento laser per miopia, astigmatismo e ipermetropia
Presentata la docuserie “Dìstances”, le storie vere e vitali di 6 donne con cancro del seno
Il 4° Convegno nazionale Ail mette a confronto sanità e impatto ambiente
E ancora
Orfeo della Sin, bimbi vanno allattati al seno almeno fino a 6 mesi. Bisogna migliorare la realtà delle donne
Aifa approva pirtobrutinib per linfoma mantellare recidivato o refrattario
Premiati a Milano i vincitori della tredicesima edizione dei Bandi di Gilead Sciences
Magi dell’Ordine dei medici di Roma, 'fermare violenze o tra poco potremmo non avere più professionisti che vogliono lavorare nel Servizio sanitario nazionale'
Durex presenta i dati dell’Osservatorio “Giovani e Sessualità”
A seguire la 1° puntata della Serie “Libertà visiva. Un nuovo modo di vedere il mondo” dal titolo: “Innovative lenti intraoculari Icl valida alternativa a intervento laser”
‘Patto per l’eliminazione dell’epatite C’, insieme società scientifiche. pazienti e istituzioni
Innovative lenti intraoculari Icl valida alternativa a intervento laser per miopia, astigmatismo e ipermetropia
Presentata la docuserie “Dìstances”, le storie vere e vitali di 6 donne con cancro del seno
Il 4° Convegno nazionale Ail mette a confronto sanità e impatto ambiente
E ancora
Orfeo della Sin, bimbi vanno allattati al seno almeno fino a 6 mesi. Bisogna migliorare la realtà delle donne
Aifa approva pirtobrutinib per linfoma mantellare recidivato o refrattario
Premiati a Milano i vincitori della tredicesima edizione dei Bandi di Gilead Sciences
Magi dell’Ordine dei medici di Roma, 'fermare violenze o tra poco potremmo non avere più professionisti che vogliono lavorare nel Servizio sanitario nazionale'
Durex presenta i dati dell’Osservatorio “Giovani e Sessualità”
A seguire la 1° puntata della Serie “Libertà visiva. Un nuovo modo di vedere il mondo” dal titolo: “Innovative lenti intraoculari Icl valida alternativa a intervento laser”
Category
🗞
NewsTranscript
00:00In this issue, the pact for the elimination of Hepatitis C, together with scientific societies,
00:17patients and institutions.
00:18Presented the documentary series Distances, the true and vital stories of six women with
00:23breast cancer.
00:25The Fourth Aisle National Convention compares health and environmental impact.
00:30And again, Orfeo della Sin, children must breastfeed at least up to six months, it is necessary to improve
00:37the reality of women.
00:38AIFA approves the top routine for lymphoma, mantle, recidivism or refractory.
00:45Awarded in Milan the winners of the thirteenth edition of the Gilead Science Awards.
00:51Maggi of the Order of the Doctors of Rome, stop violence or soon we may not have
00:56more professionals who want to work in the national health service.
01:01Durex presents the data of the observatory, youth and sexuality.
01:05To follow the first episode of the series Visual Freedom, a new way of seeing the world,
01:11from the title Innovative Intraocular Lenses ICL, a valid alternative to laser intervention.
01:22It took place in Rome the event Hepatitis C, goal elimination, the moment is now.
01:27Organizational strategies and models to rewrite the history of viral hepatitis, promoted by
01:32Gilead Sciences, which has seen the participation of institutions, scientific societies and
01:37patient associations.
01:38At the center of the meeting, the need to extend the current free screening program for
01:43Hepatitis C.
01:44Since 2020, a national screening program has been launched for Hepatitis C, which is
01:51intended for three target populations.
01:54For people born from 1969 to 1989, for people who access public services for
02:02employment, SERD and people detained in prison.
02:06This program has been financed with more than 70 million euros.
02:11Since its launch, the screening program has reached about 2 million people, but only
02:1611% of the general population between 35 and 55 years old.
02:21The data from the Ministry of Health report indicate that the screening, despite its
02:28difficulties, has managed to track more than 10,000 people.
02:33The latest data even speak of 13,000 people in Italy who have found the
02:40positive side of the screening.
02:42Today they know they have Hepatitis C, today they can be cured.
02:4650% of these people have already started treatment.
02:50So it is certainly a success that must push us to continue on this path.
02:56From the Association Hepatitis S comes a strong appeal to the government.
03:00What we think is that it is necessary to transform this screening from experimental
03:07into structural.
03:08On the other hand, the goal of the WHO is the elimination by 2030.
03:14So we ask ourselves why every year we have to sweat seven shirts to have an extension.
03:22Just like this year, because the screening ends on December 31st and the government has
03:30just refused to approve an amendment at zero cost on the extension of the band to
03:38which the screening will be carried out and on the extension.
03:41An appeal also shared by Senator Elena Piero.
03:44The goal is to eradicate Hepatitis C by 2030.
03:49It must be perennial.
03:50We must not let it slip away.
03:52For this reason, we must try to do everything necessary to extend the use of the funds
03:57from which there have been savings on the screening campaign for those who have already been tested.
04:03But if that is not enough, we must add new ones and we must expand the audience of subjects
04:09to whom this screening is addressed, expanding the age range.
04:13Only in this way can we achieve this very important goal.
04:18DISTANCES
04:21It was presented in advance at the Festa del Cinema in Rome,
04:24DISTANCES, La Vita Va Avanti Più Lontano,
04:27the Novartis docu-series made in collaboration with Salute Donna Omlus,
04:32an association of which women involved are part,
04:35which celebrates the ability to deal with the disease without losing their identity.
04:39With 30% of female oncological diagnoses and about 55,909 estimated cases in 2023,
04:46the disease is a priority for the national health system.
04:50However, thanks to the progress of scientific research and innovation in the pharmaceutical field,
04:55women can now count on a longer life expectancy and a significantly better quality of life.
05:02There is an extraordinary opportunity for innovation,
05:05a capacity that concerns not only the identification of new molecular targets
05:11or the research of new pharmacological therapies,
05:14but above all the ability to better listen to patients,
05:18what are those side effects that seem apparently low-level, low-profile, low-impact to the doctor,
05:27but which, on the other hand, experienced by patients not only for a few months but for years,
05:32can represent a really serious link.
05:35Today in Italy, over 830,000 women live with a breast cancer diagnosis,
05:40a condition that brings with it often complex therapeutic challenges.
05:44Now the world knows that oncological care, the care of tumors,
05:50is personalized thanks to innovation, not only therapeutic, but above all biological knowledge.
05:56It is not by chance that it is said personalized.
05:58Each person will have their tumor, has their tumor, will have their specific treatment targeted.
06:07But it's not just that, because we have to start looking,
06:10and we are starting to do so, at the patient, the patient in his complexity.
06:16With this series, Novartis renews its commitment to support women,
06:20not only as patients, but as people,
06:22accompanying them throughout their journey against breast cancer.
06:26The Rose Month reminds us how much research has made progress to improve and extend people's lives.
06:34But our campaign has allowed us to listen directly from the voice of women,
06:39what we still have to do.
06:41In this, we want to give hope for the commitment we will put in continuing to develop,
06:48on the one hand, innovative solutions to extend the life of patients,
06:54but on the other hand, also to take care of people.
06:58Life must be lived to the fullest, despite the disease.
07:05An important opportunity for multidisciplinary deepening
07:09on research and avant-garde themes,
07:12dedicated to the relationship between environmental impact and health risk,
07:16in order to frame a multisectoral approach
07:19to encourage policies and strategies for the protection of health
07:23as a fundamental right of the individual.
07:25This is the intention of the fourth edition of the National Convention
07:28organized by the Italian Association Against Leukemia, Lymphoma and Myeloma,
07:33held in Rome and entitled
07:35Curare è prendersi cura,
07:37impacto ambientale e rischio sanitario,
07:39benessere e stili di vita.
07:41In Italy, in fact, about half a million people live with a blood tumor
07:46and every year more than 30,000 new cases are diagnosed,
07:49but thanks to drugs they can have a life expectancy similar to those who are not ill.
07:55These cases have a genesis that naturally has to do with the environment,
08:02it also has to do with the increased life expectancy,
08:07but it also has to do with the environment.
08:09Water, land and air are vehicles of pollution today so serious
08:18that they are the cause of cardiovascular diseases, lung diseases
08:23and above all, as far as we are concerned, also rheumatological diseases.
08:27Working on this front today is essential.
08:30Prevention, unfortunately, is the seed of sanitary activities.
08:36Despite all the advances from a therapeutic point of view,
08:39in the last five decades the incidence of lymphomas has doubled significantly.
08:44It is not possible to establish exactly what caused the incidence,
08:48but certainly environmental pollution,
08:51the disproportionate use of chemical substances that then end up in the subsoil,
08:55in the sea, the pollution of seawater,
08:58which clearly leads to plastics and microplastics.
09:02There are so many chemical products that can end up on our table
09:07or that we breathe that lead to a possible increase
09:12in the development of neoplastic diseases in general, but above all rheumatological,
09:17especially if they are accompanied by alterations and mutations that we have,
09:21that we do not know, that can be altered precisely by the use of chemical substances.
09:25Medical treatments allow a better quality of life and, in some cases,
09:29also healing in the field of leukemia.
09:32These progresses do not stop, however, a substantial increase in the audience
09:35that suffers from these pathologies.
09:37In fact, we are talking about diseases of the century,
09:39but it is to be linked to the era of Anthropocene.
09:42These are human activities that have a place in being
09:45through the production of energy from fossil fuels,
09:48through industrialized agriculture,
09:51through the pollution of the air, water and soil,
09:55which determine significant impacts not only on people,
10:00but also on the environment in which we live.
10:02And so the theme today is to be able to make appropriate policies
10:07regarding these polluting sources
10:11to determine an effective reduction
10:15that is able to limit the consequent health risk
10:19and, on the other hand, which is also the theme of today's conference,
10:22is how we, as citizens, through appropriate lifestyles,
10:26can try to escape or reduce the health risk due to the environmental impact.
10:37Closing the gap. Breastfeeding sport for all.
10:40That is, to fill the gap.
10:42I support breastfeeding for everyone.
10:44And this is the theme of the World Breastfeeding Week 2024,
10:48which this year focused on the need to improve support
10:51for this important practice to reduce the existing inequalities in our society,
10:55with particular attention to times of emergency and crisis.
10:58In the last 12 years, the number of children with less than 6 months of life
11:02exclusively breastfed has increased by more than 10%,
11:05which means, based on data from the World Health Organization and UNICEF,
11:09that 48% of newborns worldwide benefit from breastfeeding,
11:12with hundreds of thousands of lives saved thanks to breastfeeding.
11:16As Luigi Orfeo, President of SIN, the Italian Society of Neonatology,
11:19emphasizes, breast milk represents, in fact,
11:22a precious shield that protects the little ones.
11:25Breast milk is a great opportunity for all newborns.
11:30It can represent a fundamental shield
11:33against infections in the first months and first years of life,
11:37all respiratory infections, bronchiolitis, pulmonitis
11:40are significantly reduced by breastfeeding.
11:44Also gastrointestinal infections, so frequent in children,
11:49are significantly reduced by being breastfed.
11:54Orfeo continues to say that the period of breastfeeding goes well beyond,
11:59lasting for a lifetime.
12:01A breastfed child, especially if breastfed for a long period,
12:05will be healthier,
12:07will be less likely to get diabetes, hypertension,
12:11will be less likely to be obese,
12:16that is, it will be a healthier adult,
12:18who will not be at risk of all those symptoms
12:22that go under the name of adult metabolic syndrome,
12:27which is a bit like the epidemic of our century.
12:32But not only, breastfeeding for a long time,
12:34continues the president of the SIN,
12:36protects the same mother from breast cancer and ovaries,
12:39and becomes in the first days the central practice
12:41in the triad mother-father-newborn,
12:43to which the father also owes and can contribute,
12:46in a convinced and safe way.
12:48But to get all these benefits,
12:50for how long should a daughter or son be breastfed?
12:53The Italian Society of Neonatology,
12:55in agreement with the World Health Organization,
12:59recommends an exclusive breastfeeding
13:02at least up to the sixth month of life.
13:05Well, we are a bit far from these numbers, from these data.
13:08We have good rates of breastfeeding up to the second or third month,
13:12but then suddenly these percentages collapse.
13:16It is clear that this is not a health choice,
13:19it is essentially a choice of personal and social type,
13:24sometimes linked to the impossibility
13:27of reconciling breastfeeding and paternity
13:31with their own working situations.
13:34This is what we all have to commit to,
13:37both we, operators of the sector,
13:39but also, of course, the public opinion,
13:42to try to improve the reality of the women who breastfeed.
13:46Therefore, Count Orfeo,
13:48the possibility of the baby's rooming-in
13:50together with the mother in all hospitals is also needed,
13:52to favor a good start in breastfeeding
13:54from the very first moments of the baby's life.
13:56Even today, however, unfortunately,
13:58at least a structure out of three does not allow it,
14:00or allows it only in a partial way.
14:02Precisely with the aim of increasing the rate of breastfeeding in hospitals,
14:05SIN, always at the forefront for promotion
14:07and the support of maternal breastfeeding,
14:09launched the three-year project
14:11Company Policy on Breastfeeding,
14:13which will end in mid-2025.
14:1562 health companies have already joined,
14:17with a total of 108 birth points,
14:19belonging to 14 of the 21 Italian regions and autonomous provinces.
14:22They include scientific companies
14:24that deal with birth control
14:26and the national federations of obstetrics and nurses.
14:28Among the targeted interventions of the project,
14:30for a greater dissemination of practices
14:32facilitating the start and duration of breastfeeding,
14:34there is also, for example,
14:36the skin-to-skin contact of a mother-born baby
14:38right from birth in the delivery room,
14:40whose effectiveness has also been confirmed
14:42by a recent prospective observational study
14:44conducted in Italy on 160 newborns,
14:46which has shown that at three months of life
14:48the percentage of breastfeeding in the exclusive breastfeeding
14:50has increased by 51% in those subjected to skin-to-skin contact
14:52at birth,
14:54compared to 53% of others.
14:56Another tool that has been very effective
14:58is telehealth and parents,
15:00which has allowed to increase by 25%
15:02the rate of exclusive breastfeeding
15:04at three months from birth,
15:06showing a positive effect even up to six months.
15:08On these bases, the study carried out
15:10and disseminated a position statement
15:12on breastfeeding telehealth.
15:14PIRTO BRUTINIB
15:18The Italian Pharmaceutical Agency
15:20has recently approved the reimbursement
15:22of PIRTO BRUTINIB,
15:24a new drug for the treatment
15:26of mammary lymphoma.
15:28This type of blood tumor,
15:30which affects about 860 people
15:32every year in Italy,
15:34originates from lymphocytes TB
15:36and often manifests in lymph nodes.
15:38PIRTO BRUTINIB, prescribed by hematologists
15:40and taken orally,
15:42is used in the treatment of patients
15:44who have already received an inhibitor
15:46but who have seen the disease reappear.
15:48This new inhibitor, PIRTO BRUTINIB,
15:50so-called non-convoluted third-generation,
15:52helps us treat these patients
15:54who otherwise would not have
15:56other therapeutic chances.
15:58I add that this new drug
16:00gives us the possibility
16:02of a complete and partial response
16:04over 50%
16:06with a good profile of toxicity.
16:08PIRTO BRUTINIB
16:10is distinguished as the first
16:12and only inhibitor of reversible PTK
16:14approved in this type of patients
16:16with an innovative action mechanism.
16:18Thanks to this peculiarity,
16:20it is able to restore a therapeutic response
16:22solid and long-lasting
16:24even in patients previously treated
16:26with a global response rate
16:28of almost 57%,
16:30as emerged from the results
16:32of the BRUIN clinical study.
16:34It is a drug that stands out
16:36for an innovative mechanism
16:38compared to the other inhibitors
16:40of PTK,
16:42which are
16:44irreversible inhibitors
16:46with a very
16:48vigorous action mechanism.
16:50PIRTO BRUTINIB
16:52is a reversible inhibitor
16:54with a much more dynamic
16:56and flexible action mechanism
16:58that continues
17:00to associate
17:02with a persistent
17:04inhibition
17:06of the molecular target
17:08and this is important
17:10because from the inhibition
17:12the therapeutic response
17:14descends.
17:16The drug produced by LILI,
17:18a company engaged in research and development
17:20for 150 years,
17:22not only has shown excellent effectiveness,
17:24but has proven well tolerated,
17:26guaranteeing a better quality of life
17:28for patients often frail and elderly.
17:30In the last 10 years we have seen
17:32a development of new therapies,
17:34new solutions
17:36for a better life of patients.
17:38For this reason,
17:40we are also committed
17:42to finding solutions for these patients
17:44who are looking for time,
17:46time to be with their family,
17:48time to live their lives
17:50and we are very proud
17:52to be able to announce today
17:54that PIRTO BRUTINIB
17:56will be available for patients in Italy.
17:58PIRTO BRUTINIB therefore marks
18:00a new era in the treatment of lymphoma
18:02offering new hopes
18:04for those who find themselves
18:06facing this disease.
18:10Changing the life and health
18:12stories of those affected
18:14by infectious diseases,
18:16oncological and hematological
18:18is the goal of the
18:20Fellowship and Community Award Program,
18:22the two bands of competition
18:24promoted by Gilead Sciences
18:26reached the 13th edition,
18:28thanks to which in the next 12 months
18:3058 projects of scientific
18:32and socio-assisting nature will come to life.
18:34The projects were awarded
18:36and during the 2024 edition
18:38entitled Stories that make history
18:40and for the winners of this year
18:4225 research projects
18:44awarded by the Fellowship Program
18:46and 33 in the socio-assisting area
18:48awarded by the Community Award Program
18:50were awarded
18:52almost 1.5 million euros.
18:54The stories that will be born
18:56thanks to the tenacity of researchers,
18:58associations of Italian patients
19:00will have a concrete impact
19:02on the lives and health
19:04of thousands of people.
19:06These initiatives mean a lot to us,
19:08I would say above all two things,
19:10collaboration and pride.
19:12We are a company whose mission
19:14is to make a healthier world
19:16for everyone.
19:18We know that we cannot do
19:20this mission alone,
19:22we have our research,
19:24even our research we do not do it alone,
19:26but only by working together
19:28with the scientific community,
19:30with the associations of patients,
19:32with the institutions,
19:34with all stakeholders
19:36we can really reach that goal.
19:38This is also why we made these
19:40Gilead bands,
19:42this is the 13th edition
19:44and this is also why
19:46we would continue to do them.
19:48All the impact we have had
19:50or that we have been able to do
19:52with these projects
19:54is a reason for pride
19:56and a reason that pushes us even more
19:58to be part of the ecosystem
20:00and of the country system in Italy.
20:02Support for Italian research
20:04of excellence and concrete support
20:06for medical-scientific innovation
20:08the Fellowship Program
20:10aims at young researchers.
20:12We are all convinced of the importance
20:14of research and innovation,
20:16but we are less aware of the fact
20:18how difficult it is for a young person
20:20to start a research path.
20:22It is much easier, unfortunately,
20:24I must say, for a senior person
20:26to obtain funding for research
20:28and much more difficult for a young person.
20:30Young people very often have
20:32much more innovative ideas,
20:34much more groundbreaking ideas than senior people.
20:36The good thing about this program
20:38is that it allows many young people
20:40to start a scientific career
20:42that very often translates
20:44into high-level results.
20:46Among the winners of the Fellowship Program 2024
20:48is a project based
20:50on neuropsychological disorders
20:52in women living with HIV.
20:54The focus of the project
20:56is to evaluate,
20:58with the scales of the questionnaires,
21:00the disorders related to depression,
21:02anxiety, sleep quality,
21:04and correlate them with the quality of life
21:06and the adherence to antiretroviral therapy.
21:08We know, in fact, that it is possible
21:10that these disorders cause a reduction
21:12of adherence, therefore with the risk
21:14of failure of treatments.
21:16Our goal is precisely to focus
21:18on identifying them early
21:20and possibly allowing the person,
21:22the woman with HIV, to manage
21:24their problem in order to improve
21:26the quality of life.
21:32Aggression to doctors
21:34and more generally to health workers
21:36is an increasingly hot topic.
21:38It does not pass the day, in fact,
21:40without the media giving news
21:42of violence by the attendants
21:44in most cases or their relatives
21:46or health personnel,
21:48especially in the emergency services,
21:50but also in ambulatories and hospitals
21:52and, moreover, in two cases out of three
21:54on women. News that, in addition
21:56to delineating a profile of strong
21:58social degradation, make the work
22:00of how many are deputies to take care
22:02of our health hardly sustainable,
22:04so much so as to distance
22:06even young people from undertaking
22:08these more than ever essential professions
22:10in a public health service.
22:12A problem is that of the violence
22:14of health workers that, for the President
22:16of the Order of the Doctors of Rome,
22:18Antonio Maggi, could put in crisis
22:20our national health service.
22:22Soon, probably, there will be no one
22:24to fight in the emergency services
22:26because there is no longer any doctor
22:28who wants to work there.
22:30And this is a serious problem,
22:32not only for doctors,
22:34but especially for citizens.
22:36And we are working a lot on this
22:38to create those conditions of serenity
22:40in the work of the doctor,
22:42not only to create and make
22:44laws that clearly increase
22:46the penalties in the case of aggression,
22:48which are certainly a deterrent.
22:50The main thing is to find
22:52solutions that are valid
22:54to protect these professionals,
22:56both with architectural barriers,
22:58but also to avoid that
23:00patients or those who come
23:02with bad intentions can have
23:04an easily direct contact
23:06with health workers.
23:08So, clearly, to create paths
23:10that are separate and therefore
23:12guarantee safety.
23:14But not only.
23:16The patient or whoever
23:18goes to see a doctor
23:20finds himself in situations
23:22where there is certainly
23:24something that does not work,
23:26he gets angry about something
23:28that does not work.
23:30Surely the bureaucracy,
23:32the waiting lists are also
23:34a serious problem.
23:36So we need to solve
23:38to suffer quietly
23:40and in the right time, let's say,
23:42the health benefits.
23:44In addition to this, there is
23:46the fact of having to educate people
23:48about the fact that the doctor
23:50is at work to help them,
23:52not certainly to create
23:54problems. It is curious
23:56that a patient who goes for a health problem
23:58then ends up going to hit
24:00the health worker who
24:02has to assist him in some way.
24:04And what else should be done
24:06We must sensitize public opinion
24:08in order to make patients understand
24:10how serious what is happening is.
24:12Because soon we may
24:14no longer have professionals
24:16who want to enter
24:18the national health service
24:20and who can somehow
24:22cure us when we need it.
24:32On the occasion of the World Hearing Day
24:34Durex Italia presented
24:36at the Centro Milano pharmacy
24:38the results of the 7th edition
24:40of the Youth and Sexuality Observatory,
24:42a research that the brand has been
24:44collaborating with Scuola.net
24:46for over 6 years on a champion
24:48of 15,000 young people between
24:50the ages of 11 and 24.
24:52The observatory tells us that
24:54young Italians are beginning
24:56to have sexual relations
24:58more and more precociously.
25:00Even a young man out of 10
25:02is more than 13 years old.
25:04A situation that also involves
25:06families where the dialogue
25:08is not always open.
25:10This lack of dialogue
25:12is also found in families.
25:14In fact, the 2024 Observatory
25:16tells us that less than 4%
25:18of young people have received
25:20information from the family
25:22about the importance
25:24of the use of condoms.
25:26This means that we are not
25:28really giving the tools
25:30to be able to face a sexual life
25:32that is free, protected
25:34and aware.
25:36In light of what emerged
25:38from the observatory,
25:40Durex proposes to provide
25:42concrete help to families
25:44to improve the dialogue
25:46between parents and children
25:48through initiatives that
25:50are part of the brand's
25:52most extensive project
25:54called A Luce Accese.
25:56Today we want to launch
25:58this initiative with Serenis.
26:00Serenis is an online medical center
26:06that is based on a network
26:08of expert psychotherapists
26:12in the field of mental well-being.
26:14With Serenis
26:16we give parents
26:18the opportunity
26:20to access free
26:22sessions
26:24with experienced
26:26psychotherapists.
26:28This gives the possibility
26:30to create tools
26:32for a dialogue within families.
26:34The other initiative
26:36that we are launching today
26:38in the context of the World Hearing Day
26:40is the one with Edulia.
26:42Edulia is the Polo eTec
26:44of Encyclopedia Treccani
26:46and with them
26:48we have always created,
26:50thanks to the support
26:52of psychotherapists
26:54and psychotherapists
26:56we have created
26:58video pills
27:00that try to guide
27:02parents
27:04to create the right
27:06environment for a dialogue
27:08with their children
27:10but also to answer
27:12questions that their children
27:14may have in the field of sexuality
27:16and affectivity.
27:18In order to create a dialogue
27:20that does not exist in families today.
27:22The projects of Durex
27:24are completely free
27:26and not linked to the purchase of products.
27:28Serenis and Durex, through the project
27:30A Luce Accese, try to give
27:32a concrete help to families
27:34to talk about topics of sexual education
27:36and affective education
27:38and they do it by offering
27:40a free first session and a psychotherapy session
27:42to families and possibly to children
27:44to learn to talk in family
27:46in an open and unembarrassed way.
27:48To use the services
27:50it is very simple
27:52just go to serenis.it
27:54slash durex
27:56and request
27:58your first session.
28:20The visual quality obtained by patients with ICL
28:22is without comparison
28:24because they see better
28:26than with glasses
28:28than with contact lenses
28:30and often also
28:32than with laser surgery
28:34so they are by far
28:36from the point of view
28:38of the highest quality
28:40in terms of visual quality
28:42and also in terms of
28:44the ability to see
28:46better than with glasses
28:48so they are by far
28:50from the point of view of quality
28:52the best solution
28:54that also has the advantage
28:56of being reversible
28:58not only updateable in the future
29:00although it is very rare
29:02that the visual defect
29:04can grow and change
29:06in a significant way
29:08during life
29:10we also know that no organ
29:12is immortal
29:14so small changes
29:16if you think of a mouth
29:18fixed by the dentist
29:20also think of an eye
29:22fixed by the ophthalmologist
29:24if small changes occur
29:26in the course of life
29:28with ICL we will have the possibility
29:30to easily correct the defect
29:32even where there was
29:34the future need
29:36simply by updating it
29:38with a visual quality
29:40always optimal
29:42with a satisfaction rate
29:44of 4% ICL
29:46is an ideal option
29:48also for those who have
29:50specific eye problems
29:52that can limit
29:54surgical alternatives
29:56improvement compared to
29:58the pre-op phase
30:00is remarkable
30:02I was going from
30:04I don't say almost blindness
30:06but we were close
30:08so the improvement is remarkable
30:10after two weeks
30:12we got much closer
30:14as a visual quality
30:16I am more free to do
30:18something that
30:20maybe before
30:22I was more limited
30:24I remember the sport
30:26I remember
30:28the gym
30:30I remember
30:32I don't know anything
30:34before I was always
30:36linked by glasses
30:38eye contact
30:40this was our
30:42last news
30:44to contact us
30:46you can write to
30:48salute-adnchronos.com
30:50thank you for following us
30:52and to the next episode